CY1109670T1 - Φαρμακευτικη συνθεση παραγωγων πιπεραζινης - Google Patents

Φαρμακευτικη συνθεση παραγωγων πιπεραζινης

Info

Publication number
CY1109670T1
CY1109670T1 CY20091101233T CY091101233T CY1109670T1 CY 1109670 T1 CY1109670 T1 CY 1109670T1 CY 20091101233 T CY20091101233 T CY 20091101233T CY 091101233 T CY091101233 T CY 091101233T CY 1109670 T1 CY1109670 T1 CY 1109670T1
Authority
CY
Cyprus
Prior art keywords
producers
piperazine
pharmaceutical composition
benzydryl
piperazines
Prior art date
Application number
CY20091101233T
Other languages
English (en)
Inventor
Domenico Fanara
Jean Scouvart
Claire Poulain
Michel Deelers
Original Assignee
Ucb Farchim S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1109670(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Farchim S.A. filed Critical Ucb Farchim S.A.
Publication of CY1109670T1 publication Critical patent/CY1109670T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μια υγρή σύνθεση που περιέχει μια δραστική ουσία που ανήκει στην οικογένεια των υποκατεστημένων βενζυδρύλ πιπεραζινών με μειωμένες ποσότητες συντηρητικών.
CY20091101233T 2004-07-14 2009-11-25 Φαρμακευτικη συνθεση παραγωγων πιπεραζινης CY1109670T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04016519 2004-07-14
EP05758582A EP1768649B1 (en) 2004-07-14 2005-07-07 Pharmaceutical composition of piperazine derivatives

Publications (1)

Publication Number Publication Date
CY1109670T1 true CY1109670T1 (el) 2014-08-13

Family

ID=34925743

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101233T CY1109670T1 (el) 2004-07-14 2009-11-25 Φαρμακευτικη συνθεση παραγωγων πιπεραζινης

Country Status (26)

Country Link
US (1) US8633194B2 (el)
EP (1) EP1768649B1 (el)
JP (1) JP4902875B2 (el)
KR (1) KR101185612B1 (el)
CN (1) CN100508981C (el)
AR (1) AR049846A1 (el)
AT (1) ATE443512T1 (el)
AU (1) AU2005261953B2 (el)
BR (1) BRPI0513257C1 (el)
CA (1) CA2573662A1 (el)
CY (1) CY1109670T1 (el)
DE (1) DE602005016802D1 (el)
EA (1) EA012463B1 (el)
ES (1) ES2332462T3 (el)
HK (1) HK1103958A1 (el)
IL (1) IL180010A0 (el)
MX (1) MX2007000230A (el)
MY (1) MY149403A (el)
NO (1) NO337768B1 (el)
NZ (1) NZ552182A (el)
PE (1) PE20060484A1 (el)
PL (1) PL1768649T3 (el)
PT (1) PT1768649E (el)
TW (1) TWI304339B (el)
WO (1) WO2006005507A2 (el)
ZA (1) ZA200700939B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
ES2910374T3 (es) 2009-03-17 2022-05-12 Nicox Ophthalmics Inc Formulaciones oftálmicas de cetirizina y procedimientos de uso
TWI503122B (zh) * 2012-02-15 2015-10-11 Taiho Pharmaceutical Co Ltd Oral administration of pharmaceutical compositions
KR102155836B1 (ko) 2013-02-22 2020-09-14 삼성전자주식회사 터치 스크린 상에서 객체 디스플레이를 제어하는 휴대 단말 및 방법
JP6843896B2 (ja) * 2017-02-13 2021-03-17 日東メディック株式会社 水性点眼点鼻用組成物
CN113712907A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种盐酸左西替利嗪滴眼液组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255358A (en) * 1978-03-13 1981-03-10 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Process for the production of hexanitrostilbene
FI75816C (fi) 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
NZ215069A (en) 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
US4728509A (en) 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
JP3278192B2 (ja) 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
TW401300B (en) 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5504113A (en) 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
CA2201134A1 (en) 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
TW536403B (en) 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
US6432961B1 (en) 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
AUPQ419099A0 (en) 1999-11-23 1999-12-16 Ko, Thomas Sai Ying Novel compositions and methods
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US6258814B1 (en) 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
AU2002221854A1 (en) 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
US6869618B2 (en) 2001-04-10 2005-03-22 Kiel Laboratories, Inc. Process for preparing tannate liquid and semi-solid dosage forms
CN1867336B (zh) 2002-06-12 2010-05-12 凯莫森特里克斯股份有限公司 1-芳基-4-取代的哌嗪衍生物及其制药用途
AU2003251152A1 (en) 2002-07-03 2004-01-23 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
EP1569650B1 (en) 2002-12-03 2008-05-28 Ucb Farchim S.A. Use of levocetirizine for the treatment of persistent allergic rhinitis
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US20090137645A1 (en) 2007-10-31 2009-05-28 Midlothian Laboratories, Llc Shelf-Stable Famotidine Granulates for Oral Suspensions

Also Published As

Publication number Publication date
MY149403A (en) 2013-08-30
BRPI0513257C1 (pt) 2021-05-25
CN100508981C (zh) 2009-07-08
PT1768649E (pt) 2009-11-13
WO2006005507A8 (en) 2006-12-07
US20070275974A1 (en) 2007-11-29
NO20070832L (no) 2007-02-13
ZA200700939B (en) 2008-08-27
EP1768649A2 (en) 2007-04-04
JP4902875B2 (ja) 2012-03-21
AU2005261953A1 (en) 2006-01-19
JP2008505949A (ja) 2008-02-28
ATE443512T1 (de) 2009-10-15
DE602005016802D1 (de) 2009-11-05
CN1984641A (zh) 2007-06-20
CA2573662A1 (en) 2006-01-19
TWI304339B (en) 2008-12-21
NZ552182A (en) 2010-07-30
HK1103958A1 (en) 2008-01-04
EP1768649B1 (en) 2009-09-23
BRPI0513257B1 (pt) 2018-05-29
MX2007000230A (es) 2007-03-30
EA012463B1 (ru) 2009-10-30
PL1768649T3 (pl) 2010-02-26
PE20060484A1 (es) 2006-07-06
US8633194B2 (en) 2014-01-21
BRPI0513257A (pt) 2008-04-29
ES2332462T3 (es) 2010-02-05
WO2006005507A2 (en) 2006-01-19
TW200605892A (en) 2006-02-16
IL180010A0 (en) 2007-05-15
KR101185612B1 (ko) 2012-09-24
NO337768B1 (no) 2016-06-20
AU2005261953B2 (en) 2010-06-03
KR20070043841A (ko) 2007-04-25
AR049846A1 (es) 2006-09-06
EA200700067A1 (ru) 2007-08-31
WO2006005507A3 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
CY1109670T1 (el) Φαρμακευτικη συνθεση παραγωγων πιπεραζινης
EA200701790A1 (ru) Твёрдый фармацевтический дозированный состав
HN2005000477A (es) Compuestos de aminoheteroarilo sustituidos con piraol como inhibidores de proteina quinasa
MX2009009552A (es) Inhibidores de metaloproteasa que contienen una porcion heterociclica.
MA32508B1 (fr) Composes organiques
UY31274A1 (es) Composiciones de recubrimiento electrodepositable que contiene una guanidina ciclica
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
CY1111269T1 (el) Ρυθμιστες βενζιμιδαζολης του vr1
ECSP099072A (es) Composiciones líquidas de fenilefrina de estabilidad mejorada
CY1110026T1 (el) Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
EA200970132A1 (ru) Аналоги морфолинила и пирролидинила
ECSP088377A (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
EA201270590A1 (ru) Ингибиторы акт
EA201491658A1 (ru) Таблетки для комбинированной терапии
EA200800698A1 (ru) Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
CL2012002948A1 (es) Formulación acuosa estable que comprende proteina almenos 5 mg/ml de proteina cd-rap y un aminoácido cargado.
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
NO20063293L (no) Farmasoytiske forbindelser
NO20055207L (no) Oralt farmasoytisk preparat for protonpumpeantagonister
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
DE602006013277D1 (de) Mehrphasige zahnpastenzusammensetzung
EA200602156A1 (ru) Новая комбинация ингибитора iтока синусового узла и кальциевого ингибитора и фармацевтические композиции, её содержащие
ATE378385T1 (de) Photostabilisierung von fluoreszenzfarbstoffen
BRPI0514469A (pt) moduladores de androgênio